Pharmacokinetics of tablet and liquid formulations of oral 6-mercaptopurine in children with acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Pharmacokinetics of tablet and liquid formulations of oral 6-mercaptopurine in children with acute lymphoblastic leukemia

Published:2020-06-09 Issue:1 Volume:86 Page:25-32
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Larsen Rikke Hebo,Hjalgrim Lisa Lyngsie,Grell Kathrine,Kristensen Kim,Pedersen Line Gerner,Brünner Emilie Damgaard,Als-Nielsen Bodil,Schmiegelow Kjeld^ORCID,Nersting Jacob^ORCID

Funder

Kræftens Bekæmpelse

Børnecancerfonden

Barncancerfonden

Nordic Cancer Union

Ingeniør Otto Christensens Fond

Region Hovedstaden

The University Hospital Rigshospitalet

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s00280-020-04097-x.pdf

Reference28 articles.

1. Toft N, Birgens H, Abrahamsson J, Griskevicius L, Hallbook H, Heyman M, Klausen TW, Jonsson OG, Palk K, Pruunsild K, Quist-Paulsen P, Vaitkeviciene G, Vettenranta K, Asberg A, Frandsen TL, Marquart HV, Madsen HO, Noren-Nystrom U, Schmiegelow K (2018) Results of NOPHO ALL2008 treatment for patients aged 1–45 years with acute lymphoblastic leukemia. Leukemia 32(3):606–615. https://doi.org/10.1038/leu.2017.265

2. Hunger SP, Mullighan CG (2015) Acute lymphoblastic leukemia in children. N Engl J Med 373(16):1541–1552. https://doi.org/10.1056/NEJMra1400972

3. Pieters R, de Groot-Kruseman H, Van der Velden V, Fiocco M, van den Berg H, de Bont E, Egeler RM, Hoogerbrugge P, Kaspers G, Van der Schoot E, De Haas V, Van Dongen J (2016) Successful therapy reduction and intensification for childhood acute lymphoblastic leukemia based on minimal residual disease monitoring: study ALL10 from the Dutch Childhood Oncology Group. J Clin Oncol 34(22):2591–2601. https://doi.org/10.1200/jco.2015.64.6364

4. Dores GM, Devesa SS, Curtis RE, Linet MS, Morton LM (2012) Acute leukemia incidence and patient survival among children and adults in the United States, 2001–2007. Blood 119(1):34–43. https://doi.org/10.1182/blood-2011-04-347872

5. Schmiegelow K, Nielsen SN, Frandsen TL, Nersting J (2014) Mercaptopurine/Methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fiction. J Pediatr Hematol Oncol 36(7):503–517. https://doi.org/10.1097/mph.0000000000000206

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A stable and sensitive 2D SERS sensor for bioanalytical applications;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2024-04

2. Bioequivalence study followed by model‐informed dose optimization of a powder for oral suspension of 6‐mercaptopurine;Pediatric Blood & Cancer;2023-12-18

3. Maintenance Treatment in Acute Lymphoblastic Leukemia: A Clinical Primer;Indian Journal of Pediatrics;2023-07-26

4. Integration of Biorelevant Pediatric Dissolution Methodology into PBPK Modeling to Predict In Vivo Performance and Bioequivalence of Generic Drugs in Pediatric Populations: a Carbamazepine Case Study;The AAPS Journal;2023-06-29

5. Enhancing cancer therapy: The potential of mercaptopurine-based nanomaterials for targeted drug delivery;Next Nanotechnology;2023-06